8,659 Call Contracts at Rs 2,600 Strike on Mankind Pharma Ltd Signal Speculative Upside Ahead of 26 May Expiry

Options Event and Cash Market Price Action

The most active call options on Mankind Pharma Ltd on 20 May were concentrated at the Rs 2,600 strike, with 8,659 contracts changing hands, generating a turnover of approximately ₹793.3 lakhs. This activity was closely followed by 5,864 contracts traded at the Rs 2,560 strike, which is nearly at the money given the underlying price of Rs 2,557.90. The open interest at Rs 2,600 stands at 1,643 contracts, while the Rs 2,560 strike has an open interest of 1,887 contracts. The contracts-to-open interest ratio at the Rs 2,600 strike is roughly 5.3:1, indicating a substantial influx of fresh positions rather than mere recycling of existing ones. Mankind Pharma Ltd outperformed its sector by 2.3% on the day, closing near its intraday high of Rs 2,573.80, reinforcing the alignment between the derivatives and cash markets — does this tandem movement signal a sustained directional conviction?

Strike Price and Moneyness Analysis

The Rs 2,600 strike calls are out-of-the-money (OTM) relative to the current stock price of Rs 2,557.90, representing a speculative bet on the stock rising approximately 1.6% within the next six trading days before expiry. The Rs 2,560 strike calls, by contrast, are effectively at-the-money (ATM), positioned to benefit from immediate directional moves. The preference for the Rs 2,600 strike suggests traders are targeting a modest upside beyond the current price, rather than hedging existing positions or betting on a near-term reversal. This strike selection reveals a speculative appetite for gains in the short term, rather than a defensive stance — what does this imply about market participants’ risk tolerance ahead of expiry?

Open Interest and Contracts Analysis

Open interest levels at both strikes remain moderate, with 1,643 contracts at Rs 2,600 and 1,887 at Rs 2,560. The contracts traded on 20 May exceed open interest by a factor of over five at the Rs 2,600 strike, signalling a surge of fresh call buying rather than position unwinding. This elevated contracts-to-OI ratio is a hallmark of new directional bets entering the market. Meanwhile, the Rs 2,560 strike shows a similar pattern, though with a slightly lower ratio of about 3.1:1. The data suggests that traders are actively establishing bullish positions rather than merely rolling over or closing existing ones. how sustainable is this fresh positioning given the proximity to expiry?

Cash Market Context: Momentum and Moving Averages

Mankind Pharma Ltd has gained 3.02% on 20 May, reversing two prior days of decline. The stock is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — indicating a strong upward momentum. This technical backdrop supports the bullish call option activity, as the derivatives market appears to be confirming the positive price trend. The stock’s intraday high of Rs 2,573.80 on the day aligns closely with the Rs 2,600 strike call activity, suggesting that traders are positioning for a breakout above this level. does this technical alignment reinforce the short-term bullish narrative?

Delivery Volume and Liquidity Considerations

Despite the surge in call option contracts, delivery volumes in the cash market have declined by 21.47% compared to the 5-day average, with 2.68 lakh shares delivered on 19 May. This divergence between rising derivatives activity and falling delivery volumes suggests that the bullish sentiment is currently more pronounced in the options market than in actual share transfers. However, the stock remains sufficiently liquid, with a traded value supporting a Rs 3.36 crore trade size based on 2% of the 5-day average. The delivery volume dip raises the question of whether the options market is anticipating a move that the cash market has yet to fully embrace — is this a sign of cautious optimism or a potential disconnect?

Key Data at a Glance

Interpreting the Combined Signals

The options flow in Mankind Pharma Ltd is unambiguous in signalling a speculative push for upside in the short term. The Rs 2,600 strike calls, trading well above the current price, represent a bet on the stock breaking higher within the next six trading days. The high contracts-to-open interest ratio confirms fresh money entering the market, rather than position adjustments. Meanwhile, the stock’s strong technical positioning above all major moving averages and a 3.02% gain on the day provide a supportive backdrop for this optimism. However, the decline in delivery volumes tempers the bullish reading, suggesting that the cash market is not yet fully participating in the rally — buy, sell, or hold Mankind Pharma Ltd given these mixed signals?

Fundamental Context

Mankind Pharma Ltd operates in the Pharmaceuticals & Biotechnology sector with a mid-cap market capitalisation of ₹1,02,278 crores. The stock’s recent price action and options activity reflect a market that is cautiously optimistic about the company’s near-term prospects, though the fundamental backdrop remains steady without dramatic shifts. The stock’s ability to sustain gains above key moving averages will be critical in validating the options market’s directional bets.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today